Role of the 5-lipooxygenase pathway in obstructive nephropathy  by Reyes, Alvaro A. et al.
Kidney International, Vol. 41(1992), pp. 100—106
Role of the 5-lipooxygenase pathway in obstructive
nephropathy
ALVARO A. REYES, JAMES LEFKOWITH, JEFFERY PIPPIN, and SAULO KLAHR
Renal Division and the Division of Rheumatology, Washington University School of Medicine, and the Department of Internal Medicine,
Jewish Hospital at Washington University Medical Center, St. Louis, Missouri, USA
Role of the 5-lipooxygenase pathway in obstructive nephropathy.
Leukotrienes are products of the 5-lipooxygenase pathway of arachi-
donic acid metabolism that possess potent inflammatory properties. We
examined the potential role of this pathway in the decrease in glomer-
ular filtration rate (GFR) and effective renal plasma flow (ERPF)
observed in rats after unilateral release of bilateral ureteral obstruction
(BUO) of 24 hours duration. Isolated glomeruli from rats with BUO
produced significantly greater amounts of leukotriene B4 (LTB4) than
glomeruli from sham-operated rats (SOR; P < 0.0001). Glomeruli from
rats with BUO given MK886, an inhibitor of the 5-lipooxygenase
enzyme, or from rats with BUO subjected to both total body irradiation
to prevent the leukocyte infiltration of the kidney and also given MK886
prior to obstruction, produced amounts of LTB4 not significantly
different from those in glomeruli of SOR. Glomeruli from rats with BUO
that had only total body irradiation prior to obstruction produced
significantly less LTB4 than glomeruli from untreated DUO rats, but
LTB4 production was still significantly greater than in glomeruli from
SOR, There were no significant differences in GFR among SOR, SOR
given MK886, and SOR subjected to total body irradiation. However,
SOR given MK886 had significantly higher ERPF and lower renal
vascular resistance (RVR) than SOR not pretreated with the lipooxy-
genase inhibitor. Rats with BUO given MK886, or subjected to total
body irradiation, or both, prior to obstruction had significantly greater
GFR and ERPF values and lower RVR than untreated BUO rats.
Glomeruli from rats with BUO which were not pretreated had three
times the leukocytes of glomeruli from SOR. This leukocyte infiltrate
was composed of macrophages (about 55%) and neutrophils (about
45%). Pretreatment with the lipooxygenase inhibitor reduced the infil-
trate by half, and total body irradiation practically abolished it. Cells
infiltrating the kidney accounted for about two-thirds and intrinsic
glomerular cells for one-third of the increase in leukotriene production
in glomeruli from obstructed kidneys. This study indicates that in-
creased synthesis of leukotrienes has a role in the hemodynamic
changes seen after unilateral release of BUO of 24 hours duration.
Marked alterations in glomerular and tubular function occur
after unilateral release of bilateral ureteral obstruction (BUO) of
24 hours duration [1]. The values for GFR and ERPF are
approximately one-third of those obtained in a single kidney of
sham-operated rats [2]. Products of arachidonic acid metabo-
lism have a role in the observed hemodynamic changes. The
activities of both cyclooxygenase and thromboxane synthase
are increased in the kidney during BUO [3—5], and the glomer-
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ular production [6] and urine excretion [71of the metabolites of
the arachidonic pathway are greater in rats with BUO than in
sham-operated rats. Increased glomerular synthesis of these
products appears to be due, at least in part, to macrophages that
infiltrate the kidney after the onset of obstruction [8]. Ei-
cosanoids, products of arachidonic acid metabolism, play an
important role in the pathophysiology of different models of
inflammatory [9, 10] and noninflammatory renal disease [11].
Interestingly, total body irradiation, a maneuver that prevents
leukocyte infiltration of the kidney, decreases the excretion of
eicosanoids in the urine of rats with BUO [7].
In the present study we examined the role of the 5-lipooxy-
genase pathway of arachidonic acid metabolism in the renal
alterations observed after unilateral release of BUO of 24 hours
duration. This metabolic pathway leads to the formation of
leukotrienes, potent chemoattractant, inflammatory and vaso-
active mediators synthesized mainly by neutrophils and macro-
phages [12]. Leukotriene B4 (LTB4) predominantly induces
leukocyte degranulation, superoxide generation and natural
killer cell activity. Leukotrienes C4, D and E4 constitute the
slow reacting substance active in anaphylaxis. At the present
time, LTB4 is the only leukotnene for which the production has
been detected and quantified in isolated glomeruli of the rat. We
used three approaches to define the role of leukotrienes in rats
with BUO. First, we measured the production of LTB4, as an
index of the activity of the 5-lipooxygenase, in glomeruli
obtained from sham-operated rats and from rats with unilater-
ally released BUO of 24 hours duration. Second, we measured
GFR and ERPF after unilateral release of BUO in rats given or
not given MK886, an inhibitor of the translocation of 5-lipoox-
ygenase from its inactive cytosolic location to its membrane-
bound active location. This results in a physiologically inactive
5-lipooxygenase [13—16]. Third, we examined the contribution
of invading leukocytes both to the glomerular production of
leukotrienes, as measured by LTB4, and to the effects of prior
total body irradiation, alone or in combination with MK886
pretreatment, on renal function after unilateral release of BUO.
Total body irradiation effectively blunts the leukocyte infiltra-
tion of the kidney seen after BUO of 24 hours duration [7]. Our
results suggest that activation of the 5-lipooxygenase pathway
of arachidonic acid metabolism results in increased synthesis of
leukotrienes during BUO. These compounds, in turn, affect
renal hemodynamics. The increased production of leukotrienes
in gloineruli of rats with BUO of 24 hours duration correlates
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with the infiltration of the kidney by macrophages and neutro-
phils.
Methods
Animals and chemicals
Female Sprague-Dawley rats, weighing 165 to 248 g (mean
211.3 5.1 g), were obtained from Sasco Inc. (Omaha, Ne-
braska, USA). After arrival the animals were housed five or six
to a cage and were fed a standard rat chow containing 22.8%
protein (Ralston Purina, St. Louis, Missouri, USA) and had
water ad libitum. Animals were housed in our facilities for at
least seven days prior to study.
The compound MK886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-
5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), an inhibitor
of the translocation of 5-lipooxygenase from its inactive cyto-
solic location to its membrane-bound active location, was from
Dr. Ford-Hutchinson (Pointe Claire-Dorval, Merck and Frosst,
Quebec, Canada). This compound was prepared for oral admin-
istration to rats according to the manufacturer's recommenda-
tions: 20 d of pre-warmed ethanol and 100 d of 0.1% methyl-
cellulose (Sigma Chemical Co., St. Louis, Missouri, USA) was
added to 10 mg of MK886 [13]. This solution was gently heated
until solubility occurred, and then 0.1% methylcellulose was
added to yield 1 ml. This compound was administered by a
stomach tube (Perfektum, New Hyde Park, New York, USA) at
a dose of 10 mg/kg body wt four hours before induction of BUO
and 12 hours before unilateral release of BUO. Inulin was
purchased from Sigma Chemical Co. and para-aminohippuric
acid (PAH) was purchased from Merck, Sharp & Dohme (West
Point, Pennsylvania, USA).
Isolation of glomeruli
This procedure was performed as described previously [17].
Under light anesthesia with intraperitoneal sodium pentobar-
bital (50 mg/kg body wt; Nembutal®, Abbot Laboratories,
Abbot Park, Illinois, USA), rats had an aortic clamp placed
above the renal arteries. The aorta was cannulated at the
bifurcation and perfused with 50 ml of pre-warmed normal
saline until blanching of the kidneys was observed. At this time
the kidneys were removed and cut sagittally, and the cortex was
separated from the medulla. Glomeruli were obtained by pass-
ing the homogenized renal cortex through sieves of succes-
sively smaller diameters. Glomeruli were counted and perme-
abilized with digestion media containing collagenase type II
(Worthington Biochemical Corp, Freehold, New Jersey, USA)
and DNAase type I (Sigma) as described to preserve viability
and maintain agonist responses [18, 19]. This method resulted in
isolated glomeruli completely devoid of contaminating circulat-
ing cells. Glomeruli were subsequently incubated in Krebs-
Henseleit buffer (approximately 30 x i03 glomeruli per 0.4 ml)
for sequential 10-minute periods. After two incubations to
stabilize the preparation, glomeruli were washed three times
and a basal period of LTB4 production was obtained. Glomeruli
were then exposed to 10 jsM ionomycin. Glomerular superna-
tants were assayed for LTB4 content by a specific radioimmu-
noassay detailed previously [17]. The values were normalized
for the number of glomeruli in the incubation and are expressed
as fmolIlO3 glomeruli.
Bilateral ureteral obstruction and sham-operation
These procedures were performed as described previously
[18]. Briefly, BUO was performed in rats under ether anesthesia
by ligating both ureters at the junction of their lower third and
upper two-thirds through a small suprapubic incision. Sham-
operation consisted of opening the abdominal cavity of rats and
manipulating but not obstructing both ureters. Both groups of
rats were returned to their cages and were allowed water but no
food prior to study, 24 hours later.
Clearance studies and blood pressure determinations
Standard clearance measurements were obtained as de-
scribed previously [9]. Briefly, with animals under light ether
anesthesia, catheters were inserted in the left femoral artery
(PE 50), left femoral vein (PE 10) and left ureter (PE 50). The
rats were secured in plastic holders, and two hours after
recovery from anesthesia were studied in the awake state. A
priming dose of chemical inulin designed to produce plasma
levels of 70 to 150 mg/dl and chemical PAH calculated to
produce plasma levels of 1 to 2 mgldl was infused in 1 ml of
normal saline over a three minute period. This was followed by
a sustained infusion delivered at 40 pilmin, which contained
sufficient inulin and PAH to maintain constant plasma levels of
these compounds. After an equilibration period of at least 60
minutes and (in rats that had sustained BUO) approximately
four hours after unilateral release of BUO, three consecutive
20-minute collections of urine and blood were obtained for
estimation of GFR by inulin clearance (C1) and ERPF by PAH
clearance (CPAH). Mean arterial pressure (MAP) was recorded
throughout the experiment by means of the femoral artery
catheter connected to a Harvard Apparatus (WECO VT-i,
Winston Electronics Co, Millbrae, California, USA).
Total body irradiation
This procedure was performed in 15 rats as described previ-
ously [7]. Forty-eight hours prior to induction of BUO or
sham-operation (72 hr prior to clearance studies and glomeruli
harvesting) the rats were anesthetized with sodium pentobar-
bital (50 mg/kg body wt) and received whole body irradiation of
1315 rads over 10 minutes (Gamma cell 40, Atomic Energy of
Canada Ltd), with shielding of the renal area.
Glomerular leukocyte quantification
Total leukocyte counts in permeabilized glomeruli were per-
formed using a double antibody fluorescence technique as
described previously [20, 21]. Mouse anti-rat leukocyte com-
mon mAb antibody (50 jg/ml) was used as the primary antibody
followed by fluorescein-conjugated rabbit anti-mouse antibody
(100 g/ml). The labeled cell content of isolated glomeruli was
evaluated by immunofluorescence microscopy with a Universal
microscope (Carl Zeiss, Thornwood, New York, USA). Cells
were focused through the glomerulus and counted as they
appeared in the plane of focus. In each experiment, 50 to 100
glomeruli were counted.
To perform differential counts, glomeruli were dissociated
into a single cell suspension by means of a previously described
enzymatic protocol [20]. Leukocytes were then stained with an
immunoperoxidase method using the same primary antibody as
above and the Zymed histostain kit from Chemicon (Temelula,
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California, USA). Cells were pelleted onto glass slides by
cytocentrifuge (Shannon, Astmore, UK), fixed in acetone,
air-dried, developed for immunoperoxidase and counterstained
with hematoxylin (Baxter). Positively labeled cells were visu-
alized by light microscopy and categorized by nuclear morphol-
ogy.
Experimental groups
Twelve groups of rats were studied. Rats sustaining 24 hour
BUO were studied immediately after unilateral release of the
obstruction; other animals were studied 24 hours after sham
operation. Groups 1 to 5 were used for isolation of glomeruli
and determination of LTB4 production. Group 1 consisted of six
sham-operated rats (SOR). Group 2 consisted of nine rats with
BUO of 24 hours duration. Group 3 consisted of six rats with
BUO given MK886 by gastric lavage (10 mg/kg body wt 4 hr
before BUO and 12 hr before unilateral release of BUO). Group
4 consisted of six rats that had total body irradiation 48 hours
prior to BUO. Group 5 consisted of five rats that received total
body irradiation 48 hours prior to BUO and in addition were
given two doses of MK886 as in group 3. Groups 6 to 8 were
used to study renal function in SOR. Group 6 consisted of five
SOR that served as temporal controls. Group 7 consisted of
four rats that were pretreated with MK886 as described above.
Group 8 consisted of three rats that received total body irradi-
ation 72 hours prior to studies. Groups 9 to 12 were used to
study renal function after unilateral release of BUO of 24 hours
duration. Group 9 consisted of six rats with BUO pretreated
with the vehicle used to dissolve the MK886. Group 10 con-
sisted of eight rats with BUO pretreated with MK886 as
described above. Group 11 consisted of four rats that received
total body irradiation 48 hours prior to BUO. Group 12 con-
sisted of five rats that received total body irradiation 48 hours
prior to BUO and were given MK886 as in group 3.
Leukotriene B4 measurements and other analytic
determinations
The production of LTB4 from isolated glomeruli obtained
from rats of groups 1 to 5 was measured by radioimmunoassay
as described previously [18—20]. Sodium and potassium were
measured by standard flame photometry (Instrumentation Lab-
oratory Inc. Lexington, Massachusetts, USA). Inulin was de-
termined using the anthrone method [22] and PAH was mea-
sured by a modification of the method of Smith et al [23].
Calculations
Clearance values for inulin and PAH were calculated using
standard formulas. Renal vascular resistance (RVR) was calcu-
lated according to the formula MAP/ERPF(l-hematocrit). For
each rat the values of three consecutive clearance periods were
averaged. Analysis of variance was used for comparisons
among different groups for the several determinations per-
formed. Differences were considered significant when P < 0.05.
Results
Figure 1 depicts the production of LTB4 in isolated glomeruli
from sham-operated rats (group 1), rats with BUO (group 2),
rats with BUO given MK886 (group 3), rats subjected to total
body irradiation prior to BUO (group 4) and rats subjected to
LJIL
BUO+ BUO+ BUO+
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Fig. 1. Production of leukotriene B4 by isolated glomeruli obtained
from sham-operated rats (SOR), rats with bilateral ureteral obstruction
'BUO), rats with bilateral ureteral obstruction pretreated with the
inhibitor of the 5-lipooxygenase MK886 (BUO -I- MK886), rats with
bilateral ureteral obstruction subjected to total body irradiation (BUO
+ TB!), and rats subjected to both total body irradiation and adminis-
tration of MKSS6 prior to obstruction (BUO + TBI + MK886).
Glomeruli obtained from rats with BUO produced significantly greater
amounts of leukotriene B4 than glomeruli from SOR (*P <0.01). It is of
note that all of the maneuvers that inhibited lipooxygenase activity
(MK886) or prevented the leukocyte infiltration of the kidney (TBI)
resulted in a marked and significant decrease in the production of
leukotriene B. by isolated glomeruli (*P < 0.01). Glomeruli obtained
from rats with BUO subjected to total body irradiation prior to
obstruction produced significantly greater amounts of leukotriene B4
than glomeruli from SOR (** < 0.01).
total body irradiation which also received MK886 prior to BUO
(group 5). Glomeruli from rats with BUO produced significantly
more LTB4 (99.0 15.0 fmol/103 glomeruli) after stimulation
with ionomycin than isolated glomeruli obtained from sham-
operated rats (7.3 1.6 fmol/103 glomeruli). The different
maneuvers employed decreased significantly the production of
LTB4 in glomeruli of rats with BUO (groups 3 to 5) compared to
untreated BUO rats. The production of LTB4 in glomeruli of
rats with BUO given MK886 (12.0 3.0 fmol/103 glomeruli) or
given MK886 and also subjected to total body irradiation (16.0
4.0 fmol/103 glomeruli) was not significantly different from
the production of LTB4 in glomeruli from SOR. The production
of LTB4 in glomeruli obtained from BUO rats subjected only to
total body irradiation was significantly lower (39.0 2.0 fmoll
l0 glomeruli) than that obtained in untreated BUO rats.
However, this value was significantly greater than that obtained
in glomeruli from SOR.
To determine the effects on renal function of inhibiting
5-lipooxygenase in the setting of obstruction, we obtained
standard clearance measurements in SOR (groups 6 and 7) and
rats with BUO (groups 9 to 12) in which different maneuvers
were used to modify the production of leukotrienes, There were
no significant differences in body weight, urine flow rates,
fractional sodium excretion or fractional water excretion be-
tween the two sham-operated groups (Table 1). However,
absolute sodium excretion was significantly lower in SOR given
MK886 than in temporal controls. There were no significant
differences in body weight among the different groups of rats
with BUO (Table 1). Absolute sodium excretion, but not
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Table 1. Body weights, absolute and fractional sodium and water excretion in two groups of SOR and four groups of rats with BUO in which
renal function was measured
Group
.
Body weight
g
.Urine flow
d/,nin
UVNa
Eq/min
FENa FEHO2
%
Sham-operated rats
Temporal controls 6 219 6 18.7 5.5 5.8 1.3 0.8 0.1 2.4 0.6
SOR + MK886 7 220 5 13.1 3.0 1.8 0.6 0.98 0.31 0.9 0.2
Rats with BUO
Temporal controls 9 193 5 35.5 5.2 3.6 0.7 9.8 1.8 13.8 1.5
BUO + MK886 10 214 9 38.5 3.0 3.6 0.5 3.9 0.7a 6.3 0.9k
BUO + TBI 11 203 3 51.8 8.5 5.4 1.4 5.6 1.4k 8.3 l.3
BUO + MK886 + TBI 12 207 6 66.8 6.l 8.0 0.6a 8.1 0.7 13,4 0.7
Abbreviations are: SOR, sham-operated rats; BUO, bilateral ureteral obstruction; TB!, total body irradiation; UVNa, absolute sodium urine
excretion; FENa, fractional sodium excretion; FEH,o, free water clearance.
a P < 0.05 when compared to temporal controls
Table 2. Renal function, mean arterial blood pressure and renal vascular resistance in sham-operated rats and rats with bilateral ureteral
obstruction
Group
GFR ERPF
MAP
mm Hg
RVR
mm Hg/mi!
mm/kgmi/mm/kg
Sham-operated rats
Temporal controls 6 6.37 0.33 21.5 0.8 119 1 3.15 0.13
SOR + MK886 7 6.63 0.53 28.9 1.5 123 2 1.26 o.o6
SOR + TB! 8 6.80 0.47 ND 120 1 ND
Rats with BUO
Temporal controls 9 1.37 0.14 2.38 0.17 158 5 37.0 2.9
BUO + MK886 10 3.15 0.32a 11.4 l.oa 153 4 8.2 o.8
BUO + TBI 11 3.33 0.73a 7.77 0.23a 164 5 8.4 l.9a
BUO + MK886 + TBI 12 3.16 0.27a 7.99 l.l7 149 8 10.5 3.2a
Abbreviations are: SOR, sham-operated rats; BUO, bilateral ureteral obstruction; MAP, mean arterial pressure; TB!, total body irradiation;
ERPF, effective renal plasma flow; GFR, glomerular filtration rate; RVR, renal vascular resistance; ND, not determined.
a p < 0.05 when compared to temporal controls
fractional sodium or fractional water excretion, was signifi-
cantly greater in rats of group 12 than in untreated BUO rats
(group 9). In contrast, rats with BUO given MK886 (group 10)
or subjected to total body irradiation (group 11) had signifi-
cantly lower fractional sodium and fractional water excretion
than untreated BUO rats (group 9). Table I shows that rats of
group 12 had significantly greater urine flow than temporal
controls.
Table 2 summarizes the values for GFR, as measured by C1,
ERPF, as measured by CPAH, MAP and RVR obtained in SOR
(groups 6 to 8) and rats with BUO (groups 9 to 12). Untreated
BUO rats (group 9) had a significantly lower GFR (about 80%
lower), ERPF (about 90% lower) and higher MAP (about 33%
increase) and RVR (about a 12-fold increase) than SOR that
served as temporal controls (group 6). There were no significant
differences in GFR or MAP among the different groups of SOR.
However, rats with SOR given MK886 (group 7) had signifi-
cantly higher ERPF and lower RVR than untreated SOR (group
6). Due to a laboratory accident, it was not possible to deter-
mine ERPF or RVR in SOR subjected to total body irradiation
(group 8). There were no significant differences in MAP among
the different groups of rats with BUO. Despite this, the different
maneuvers used to decrease leukotriene production in these
rats (groups 10 to 12) resulted in significantly higher values for
GFR and ERPF and significantly lower values for RVR than the
ones obtained in untreated BUO rats (group 9). Although rats
with BUO given MK886 (group 10) tended to have higher values
for ERPF than the other BUO groups tested, the values for
RVR were not significantly different from those observed in rats
with BUO undergoing total body irradiation (group 11) or rats
with BUO subjected to total body irradiation and given MK886
(group 12).
Figure 2 summarizes the results of total leukocyte counts in
glomeruli obtained from SOR and BUO rats. Glomeruli ob-
tained from SOR had fewer leukocytes than glomeruli from
untreated BUO rats. Interestingly, the infiltrate in the glomeruli
from untreated BUO rats was mixed and composed not only of
macrophages (54%) but also of neutrophils (46%), and to the
best of our knowledge this constitutes the first demonstration of
a role for neutrophils as invaders of the glomerulus in the setting
of BUO in the rat. In glomeruli obtained from rats given MK886
prior to BUO of 24 hours duration the leukocyte infiltrate was
reduced by about one-half. Prior irradiation of rats that had
BUO almost completely prevented the leukocyte infiltration of
the glomeruli.
Discussion
The results of this study demonstrate a significant increase in
the glomerular production of LTB4 after BUO of 24 hours
duration. This increase was blunted by the administration in
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Fig. 2. Leukocytes present in glomeruli of sham-operated rats (SOR)
or rats with bilateral ureteral obstruction (BUO). Rats with BUO had a
greater number of leukocytes per glomerulus than sham-operated rats
(SOR), and the infiltrate consisted of macrophages (U) and neutrophils
(a). Neutrophils were practically absent in glomeruli from SOR. BUO
rats pretreated with MK886, the inhibitor of 5-Jipooxygenase, showed a
marked decrease in the glomerular infiltrate by leukocytes. In rats
subjected to total body irradiation (TBI) prior to BUO the leukocyte
infiltrate was almost completely abrogated.
vivo of an inhibitor of 5-lipooxygenase prior to obstruction and
isolation of glomeruli, by total body irradiation prior to BUO, or
by the combination of these two maneuvers, At the same time
the renal functional studies demonstrated that inhibition of
5-lipooxygenase with MK886 or prevention of the leukocyte
infiltrate in the kidney during obstruction with either MK886 or
total body irradiation ameliorated the decrease in GFR and
ERPF observed after unilateral release of bilateral ureteral
obstruction. The greater values for GFR and ERPF after
5-lipooxygenase inhibition or prevention of the leukocyte infil-
tration were not accompanied by marked changes in systemic
blood pressure, suggesting that these maneuvers very likely
modified intrarenal hemodynamics. In fact, they resulted in
significant reductions in renal vascular resistance to about
one-fourth of the values obtained in untreated BUO rats (group
9). However, the present studies do not allow us to determine
whether the decrease in GFR was due to a fall in the ultrafil-
tration coefficient (K1), a fall in intraglomerular pressure or a
combination of both.
The tubuloglomerular balance of the different groups of rats
after release of BUO deserves some comment. Values for GFR
after release of BUO in temporal controls were about one-fifth
those of untreated SOR (Table 2) and urine flow values were
about twofold those obtained per one kidney in untreated SOR
(Table 1). Fractional sodium and water excretions were mark-
edly increased after release of BUO of 24 hours duration. The
basis for this postobstructive diuresis is not completely under-
stood, but factors such as resistance of distal tubular segments
to vasopressin [241, an osmotic diuresis [25] and increased
levels of atrial natriuretic peptide [261 may contribute to its
occurrence. In the present study, rats given MK886 prior to
BUO had fractional sodium and water excretions that were
lower than the values in untreated BUO rats (group 9). This is
probably due to the greater filtered load of sodium and water as
a consequence of the increase in GFR. Rats subjected to total
body irradiation prior to BUO had urine flow values and
fractional excretions of sodium and water that were greater than
in BUO rats given MK886. This occurred despite comparable
filtered loads of sodium and water. In rats subjected to total
body irradiation and also given MK886 prior to BUO, the
filtered load of sodium and water was twice as great as in rats
with BUO not treated. However, the fractional excretion of
sodium and water did not differ from that of untreated BUO rats
(group 9). This suggests a potential diuretic and natriuretic
effect brought about by the irradiation treatment. The mecha-
nisms underlying this effect are not readily apparent.
Measurements of LTB4 were performed in isolated glomeruli
that were perfused with normal saline and devoid of circulating
cells. This method of glomeruli isolation has been shown to
result in glomeruli that only contain resident macrophages and
other cells that have previously invaded the kidney [17]. The
present results are in agreement with previous reports of the
ability of glomeruli to synthesize leukotrienes after immunolog-
ical injury to the kidneys. Schreiner and Leficowith in the
nephrotoxic-induced serum nephritis model (NSN) [17, 19, 20],
Lianos in the passive Heymann nephritis and the NSN model
[11, 27] and Rahman et al in cationic gamma globulin-induced
glomerulonephritis [28] have demonstrated increased produc-
tion of LTB4 by isolated glomeruli. The increased production of
LTB4 observed in isolated glomeruli obtained from rats with
BUO correlates with the inflammatory infiltrate observed after
ureteral obstruction of 24 hours duration. Thus, the increased
production of LTB4 by isolated glomeruli may be in part the
result of leukocyte infiltration. After BUO of 24 hours duration
we found a significant leukocyte infiltration in the kidney,
composed mainly of macrophages and neutrophils. This leuko-
cyte invasion peaks between 12 and 24 hours after the onset of
obstruction [81 and its onset at four hours after obstruction is
temporally related to the initial decrease in ERPF, indicating
active production (or modulation) of vasoconstrictor sub-
stances by these cells. Abrogation of the infiltrate by total body
irradiation or its significant reduction by MK886 ameliorated
the decrease in GFR and ERPF observed after unilateral release
of BUO, and was correlated with decreased production of LTB4
by isolated glomeruli. This suggests that the invasion of the
kidney by macrophages and neutrophils after BUO significantly
increased the ability of glomeruli to synthesize leukotrienes and
affected renal hemodynamics. Glomeruli obtained from rats
that were given MK886 prior to BUO showed a 90% reduction
in the synthesis of leukotrienes, as monitored by LTB4 produc-
tion compared to untreated BUO rats. Complete abrogation of
the leukocyte infiltrate by total body irradiation reduced pro-
duction of LTB4 to 60% of the values seen in untreated BUO
rats. On the other hand, partial reduction of the leukocyte
infiltrate with MK886 decreased the production of LTB4 to
levels similar to those obtained in sham-operated rats. These
observations suggest that cells intrinsic to the glomerulus
account for about one-third of the total increase in leukotriene
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production found in this setting. All the increase in leukotriene
production seen after BUO of 24 hours duration was completely
abolished by an inhibitor of the activation of 5-lipooxygenase.
This suggests that the inhibitor affected LTB4 production in
both intrinsic glomerular cells and invading leukocytes.
Studies designed to examine the effect of inhibition of 5-li-
pooxygenase with MK886 on the leukocyte infiltrate of glomer-
uli revealed a decrease of approximately 50% in the leukocyte
infiltrate in treated BUO rats compared to values observed in
untreated BUO rats (Fig. 2). Thus, inhibition of 5-lipooxygen-
ase in rats with BUO resulted in: 1) reduction in the glomerular
production of leukotrienes, as assessed by LTB4 measure-
ments; 2) glomerular decrease in the leukocyte infiltrate; and, 3)
significant amelioration of the decrease in GFR and ERPF. The
fact that the inhibition of leukotriene synthesis in rats with BUO
partially prevented the macrophage and neutrophil infiltration
suggests that a product of the lipooxygenase pathway of ara-
chidonic acid metabolism may be a key chemotactic factor for
these cells during obstruction of the urinary tract. The im-
proved renal hemodynamics seen in rats with BUO given
MK886 may be due to the combined effects of decreasing the
macrophage infiltrate and to a decrease in leukotriene produc-
tion by circulating and/or intrinsic cells of the kidney. These
leukotrienes were probably those with vasoactive properties of
the C4, or D4 series. In the present studies the glomerular
production of other metabolites of arachidonic acid such as the
cysteinil-containing leukotrienes C4, D4 and E4 was not detect-
able with specific radioimmunoassay techniques (data not
shown), suggesting that such levels are very low and/or that
these leukotrienes are synthesized only by circulating cells. It is
possible that the observed beneficial effect of 5-lipooxygenase
inhibition on renal hemodynamics could be due to decreased
synthesis of leukotrienes with vasoconstrictor properties such
as leukotrienes of the C4 and D4 series, and the prevention of a
leukocyte infiltrate in the glomeruli. Such leukocytes, mainly
macrophages, are capable of releasing thromboxane A2, an-
other vasoconstrictor that contributes to the renal hemody-
namic changes [7].
Studies by Badr et at [29, 30] have demonstrated that leuko-
trienes affect renal hemodynamics. In anesthetized rats infusion
of LTC4 produced a significant increase in MAP and a decrease
in renal plasma flow [29]. Micropuncture studies demonstrated
that LTD4 reduced glomerular plasma flow and the ultrafiltra-
tion coefficient (K1) [30]. In addition, in vitro studies suggest
that the decrease of Kf observed after administration of LTC4
and D4 in vivo may be due to mesangial cell contraction with a
decrease in the surface area available for filtration [31, 32]. Our
studies in rats with BUO that had received total body irradia-
tion and/or MK886 demonstrated amelioration of the decrease
in ERPF and GFR without significant changes in systemic blood
pressure, and this improvement was accompanied by a signifi-
cant decrease in renal vascular resistance. Whether this de-
crease was associated with an increase in intraglomerular
pressure and/or an increase in Kf could not be determined from
the present studies.
In summary, we report a significant increase in the produc-
tion of leukotrienes, as determined by LTB4 synthesis, in
isolated glomeruli obtained from rats with BUO of 24 hours
duration, suggesting an increase in the biological activity of the
5-lipooxygenase pathway of arachidonic acid metabolism. Prior
inhibition of the activation of this enzyme or prevention of the
macrophage and neutrophil infiltrate to the kidney by total body
irradiation or MK886 administration ameliorated the decrease
in GFR and ERPF seen after unilateral release of BUO of 24
hours duration. This suggests an increased synthesis of metab-
olites of this pathway with chemoattractant properties (LTB4),
but also very likely other metabolites with vasoconstrictive
activity (leukotrienes C4 and D4). Inhibition of 5-lipooxygenase
with MK886 or pretreatment with total body irradiation de-
creased the synthesis of leukotriene in glomeruli and prevented
the macrophage and neutrophil infiltrate. This suggests that a
product(s) of the 5-lipooxygenase pathway of arachidonic acid
metabolism may be a chemotactic factor for the leukocyte
infiltration of glomeruli. Although the infiltrating leukocytes
appear to be an important source of increased leukotriene
synthesis in glomeruli, resident glomerular cells account for at
least one-third of the production of leukotrienes after BUO of
24 hours duration. We conclude that increased synthesis of
leukotrienes may play an important role in the altered hemody-
namics seen after unilateral release of BUO of 24 hours dura-
tion.
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